Cognizant Technology Solutions
CTSHBusiness Overview
ticker: CTSH step: 01 generated: 2026-05-12 source: quick-research
Cognizant Technology Solutions Corporation (CTSH) — Business Overview
Business Description
Cognizant Technology Solutions is one of the world's largest IT services and consulting firms, headquartered in Teaneck, New Jersey with a majority of its delivery workforce (~350,000 employees) based in India. The company provides digital transformation, technology implementation, and IT outsourcing services to global enterprises across financial services, healthcare, manufacturing, retail, and media industries. After several years of flat revenue growth, Cognizant is repositioning itself as an "AI builder" with 1,200 active AI projects and a dedicated AI Factory platform co-developed with Dell and NVIDIA to help clients industrialize generative AI at enterprise scale.
Revenue Model
Cognizant generates revenue primarily through time-and-materials and fixed-price contracts for managed services, consulting engagements, and software implementation. Revenue is driven by headcount deployed on client projects; the company's offshore-heavy model (India-based delivery teams at lower cost structures than onshore) generates margins through labor arbitrage. A growing share of revenue comes from higher-value, higher-margin AI, data, and cloud modernization services that carry better pricing than traditional application management outsourcing. Bookings (total contract value) are a leading indicator of future revenue growth.
Products & Services
- Digital transformation consulting and strategy
- AI and generative AI implementation (AI Factory with Dell/NVIDIA)
- Cloud migration and infrastructure modernization
- Application development, maintenance, and management (ADM)
- Data modernization and analytics
- Enterprise resource planning (SAP, Oracle implementations)
- Cybersecurity and compliance services
- Business process outsourcing (BPO) in healthcare, finance operations
Customer Base & Go-to-Market
Cognizant serves large global enterprises (Fortune 500) primarily in regulated industries — financial services, health sciences, retail/CPG, and communications. Long-term managed services contracts (3–7 years) provide revenue visibility; large deals (>$100M TCV) are a key growth lever, with 12 such deals closed in Q4 2025 alone (+60% in TCV vs. the year before). The company sells through direct account relationships, with account managers embedded at major clients; Health Sciences and Financial Services are the largest and fastest-growing verticals.
Competitive Position
Cognizant competes directly with Infosys, Wipro, TCS (Tata Consultancy Services), HCL Technologies, and Accenture. Its competitive positioning is between the purely offshore Indian IT peers and full-service consultancies. Recent large-deal wins and AI partnerships (AI Factory, Adobe, Uniphore, Typeface) signal a credible pivot toward higher-value services. The company's U.S.-listed structure (NASDAQ) and hybrid onshore/offshore delivery model make it particularly appealing to U.S. enterprise clients with data sovereignty and compliance requirements.
Key Facts
- Founded: 1994 (originally Dun & Bradstreet Software)
- Headquarters: Teaneck, NJ (delivery centers primarily in India)
- Employees: ~350,000
- Exchange: NASDAQ
- Sector / Industry: Technology / IT Services & Consulting
- Market Cap: ~$35B
Financial Snapshot
ticker: CTSH step: 04 generated: 2026-05-12 source: quick-research
Cognizant Technology Solutions Corporation (CTSH) — Financial Snapshot
Income Statement Summary
| Metric | FY2022 | FY2023 | FY2024 | YoY |
|---|---|---|---|---|
| Revenue | ~$19.4B | $19.4B | $19.7B | +2.0% |
| Gross Margin | ~31% | ~31% | ~32% | |
| Adj. Operating Margin | ~15.3% | ~15.3% | ~15.3% | flat |
| Net Income (adj) | ~$2.0B | ~$2.15B | ~$2.2B | |
| Adj. EPS | $4.42 | $4.21 | ~$4.75 |
Note: 2023 revenue declined slightly (-0.4%) due to post-pandemic IT spending digestion across enterprise clients. Recovery began in late 2023; full-year bookings of $26.3B in 2023 (+9% YoY) foreshadowed the 2024 recovery. Adj. EPS declined in 2023 due to investments in the NextGen program; 2024 showed recovery.
Cash Flow & Balance Sheet (FY2024)
| Metric | Value |
|---|---|
| Operating Cash Flow | ~$2.5B (est.) |
| Free Cash Flow | ~$2.2B (est.) |
| Cash & Equivalents | ~$2.8B |
| Total Debt | ~$0.8B (low leverage) |
Key Ratios (approximate)
- P/E: ~15x | EV/EBITDA: ~12x | FCF Yield: ~6%
- Dividend Yield: ~1.6% | Adj. Operating Margin: 15.3–15.8%
- Share Repurchase Authorization: $3.1B ($1.6B targeted for 2026)
Growth Profile
Revenue growth was flat from 2022–2023 as enterprise IT budgets were cut post-pandemic. The 2024 recovery (+2%) and 2025 acceleration (+7% to $21.1B) reflect large-deal wins in AI/cloud transformation and Health Sciences growth. Adjusted operating margin improved from 15.3% to 15.8% in 2025 via NextGen cost efficiencies. The company targets sustained mid-single-digit organic revenue growth with margin expansion of 20–40 bps per year.
Forward Estimates
- FY2025 Revenue: $21.1B (+7%); Adj. EPS: $5.22–$5.26 (raised guidance)
- FY2026E: Revenue ~$22–23B; EPS ~$5.60–$5.80
- Capital Return 2026: $1.6B in buybacks + dividends
- Bookings Trend: Record large-deal TCV in 2025; 60% YoY growth in >$100M deals
Deeper Financial Analysis
The fundamental tier adds 9 additional research dimensions for $CTSH.